Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (23)
Anusorn Thampithak, Kessarin Chaisiri, Onrumpa Siangsuebchart, Kamonchanok Phengjaturat, Wiwarin Aonjumras & Jatapat Hemapanpairoa. (2022) Prescription Pattern of Intravenous Fosfomycin in a Provincial Hospital in Thailand. Infection & Chemotherapy 54:4, pages 699.
Crossref
Crossref
Giuseppe Mancuso, Angelina Midiri, Elisabetta Gerace & Carmelo Biondo. (2021) Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens 10:10, pages 1310.
Crossref
Crossref
Nalumon Thadtapong, Soraya Chaturongakul, Sunhapas Soodvilai & Padungsri Dubbs. (2021) Colistin and Carbapenem-Resistant Acinetobacter baumannii Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling. Antibiotics 10:9, pages 1054.
Crossref
Crossref
Xiao Sun, Yange Feng, Bingqiao Wang, Ying Liu, Zishuai Wu, Di Yang, Youbin Zheng, Jialiang Peng, Min Feng & Daoai Wang. (2021) A new method for the electrostatic manipulation of droplet movement by triboelectric nanogenerator. Nano Energy 86, pages 106115.
Crossref
Crossref
Jacinda C. Abdul-Mutakabbir, Juwon Yim, Logan Nguyen, Philip T. Maassen, Kyle Stamper, Zain Shiekh, Razieh Kebriaei, Ryan K. Shields, Mariana Castanheira, Keith S. Kaye & Michael J. Rybak. (2021) In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii. Antibiotics 10:7, pages 880.
Crossref
Crossref
Song Oh, Raymond Chau, Anh T. Nguyen & Justin R. Lenhard. (2021) Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?. Antibiotics 10:6, pages 646.
Crossref
Crossref
Loukas Kakoullis, Eleni Papachristodoulou, Paraskevi Chra & George Panos. (2021) Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic Solutions. Antibiotics 10:4, pages 415.
Crossref
Crossref
Weerayuth Saelim, Dhitiwat Changpradub, Sudaluck Thunyaharn, Piraporn Juntanawiwat, Parnrada Nulsopapon & Wichai Santimaleeworagun. (2021)
Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant
Acinetobacter baumannii
: Improved Efficacy or Decreased Risk of Nephrotoxicity?
. Infection & Chemotherapy 53:1, pages 128.
Crossref
Crossref
Uthaibhorn Singkham-in, Paul G. Higgins, Dhammika Leshan Wannigama, Parichart Hongsing & Tanittha Chatsuwan. (2020) Rescued chlorhexidine activity by resveratrol against carbapenem-resistant Acinetobacter baumannii via down-regulation of AdeB efflux pump. PLOS ONE 15:12, pages e0243082.
Crossref
Crossref
Stamatis Karakonstantis, Evangelos I Kritsotakis & Achilleas Gikas. (2020) Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems. Infection 48:6, pages 835-851.
Crossref
Crossref
Jacinda C. Abdul‐Mutakabbir, Sara Alosaimy, Taylor Morrisette, Razieh Kebriaei & Michael J. Rybak. (2020) Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:12, pages 1228-1247.
Crossref
Crossref
Kamonwan Lunha, Khin Thet Thet, Arisa Ngudsuntia, Nicha Charoensri, Aroonlug Lulitanond, Ratree Tavichakorntrakool, Lumyai Wonglakorn, Kiatichai Faksri & Aroonwadee Chanawong. (2020) PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii. Infection, Genetics and Evolution 85, pages 104577.
Crossref
Crossref
Roberta Maria Antonello, Luigi Principe, Alberto Enrico Maraolo, Valentina Viaggi, Riccardo Pol, Massimiliano Fabbiani, Francesca Montagnani, Antonio Lovecchio, Roberto Luzzati & Stefano Di Bella. (2020) Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies. Antibiotics 9:8, pages 500.
Crossref
Crossref
Supanun Pungcharoenkijkul, Jantima Traipattanakul, Sudaluck Thunyaharn & Wichai Santimaleeworagun. (2020) Antimicrobials as Single and Combination Therapy for Colistin-Resistant Pseudomonas aeruginosa at a University Hospital in Thailand. Antibiotics 9:8, pages 475.
Crossref
Crossref
Khin Thet Thet, Kamonwan Lunha, Arpasiri Srisrattakarn, Aroonlug Lulitanond, Ratree Tavichakorntrakool, Waewta Kuwatjanakul, Nicha Charoensri & Aroonwadee Chanawong. (2020) Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital. World Journal of Microbiology and Biotechnology 36:7.
Crossref
Crossref
Yale Wang, He Li, Xiaoqian Xie, XiaoHan Wu, Xinxin Li, Zeyue Zhao, Shasha Luo, Zhijie Wan, Jingjing Liu, Lei Fu & Xiaotian Li. (2020) In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli. Journal of Global Antimicrobial Resistance 20, pages 351-359.
Crossref
Crossref
Georgios Papathanakos, Ioannis Andrianopoulos, Athanasios Papathanasiou, Efthalia Priavali, Despoina Koulenti & Vasilios Koulouras. (2020) Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients. Microorganisms 8:2, pages 287.
Crossref
Crossref
Matteo Bassetti, Elena Graziano, Marco Berruti & Daniele Roberto Giacobbe. (2019) The role of fosfomycin for multidrug-resistant gram-negative infections. Current Opinion in Infectious Diseases 32:6, pages 617-625.
Crossref
Crossref
Zekun Li, Yuping Cao, Lingxian Yi, Jian-Hua Liu & Qiwen Yang. (2019) Emergent Polymyxin Resistance: End of an Era?. Open Forum Infectious Diseases 6:10.
Crossref
Crossref
Yaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar, David Schwartz, Amir Nutman, Vered Daitch, Dafna Yahav, Leonard Leibovici, Anna Skiada, Anastasia Antoniadou, George L Daikos, Roberto Andini, Rosa Zampino, Emanuele Durante-Mangoni, Johan W Mouton, Lena E Friberg, Yael Dishon Benattar, Roni Bitterman, Ami Neuberger, Yehuda Carmeli, Mical Paul, Mical Paul, Yael Dishon Benattar, Yaakov Dickstein, Roni Bitterman, Hiba Zayyad, Fidi Koppel, Yael Zak-Doron, Sergey Altunin, Nizar Andria, Ami Neuberger, Anat Stern, Neta Petersiel, Marina Raines, Amir Karban, Leonard Leibovici, Dafna Yahav, Noa Eliakim-Raz, Oren Zusman, Michal Elbaz, Heyam Atamna, Vered Daitch, Tanya Babich, Yehuda Carmeli, Amir Nutman, Amos Adler, Inbar Levi, George L Daikos, Anna Skiada, Ioannis Pavleas, Anastasia Antoniadou, Antigoni Kotsaki, Emanuele Durante-Mangoni, Roberto Andini, Domenico Iossa, Mariano Bernardo, Giusi Cavezza, Lorenzo Bertolino, Giuseppe Giuffre, Roberto Giurazza, Susanna Cuccurullo, Maria Galdo, Patrizia Murino, Adriano Cristinziano, Antonio Corcione, Rosa Zampino & Pia Clara Pafundi. (2019) Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial. Clinical Infectious Diseases 69:5, pages 769-776.
Crossref
Crossref
Hye Jung Park, Jae Hwa Cho, Hyung Jung Kim, Sang Hoon Han, Seok Hoon Jeong & Min Kwang Byun. (2019) Colistin monotherapy versus colistin/rifampicin combination therapy in pneumonia caused by colistin-resistant Acinetobacter baumannii: A randomised controlled trial. Journal of Global Antimicrobial Resistance 17, pages 66-71.
Crossref
Crossref
Jin Wang, Hui Niu, Rui Wang & Yun Cai. (2019) Safety and efficacy of colistin alone or in combination in adults with Acinetobacter baumannii infection: A systematic review and meta-analysis. International Journal of Antimicrobial Agents 53:4, pages 383-400.
Crossref
Crossref
Alessandra Oliva, Stefania Garzoli, Massimiliano De Angelis, Carolina Marzuillo, Vincenzo Vullo, Claudio Mastroianni & Rino Ragno. (2019) In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant Acinetobacter Baumannii. Molecules 24:5, pages 886.
Crossref
Crossref